StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Reviva Pharmaceuticals's cash was $17.46M at Sep 30, 2026. For fiscal 2025 it was $14.44M, up 7.1% from the year before. The highest annual figure on record is $29.69M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.44M+7.1%
FY2024Dec 31, 2024$13.48M-42.3%
FY2023Dec 31, 2023$23.37M+26.2%
FY2022Dec 31, 2022$18.52M-37.6%
FY2021Dec 31, 2021$29.69M+238.9%
FY2020Dec 31, 2020$8.76M+4538999.5%
FY2019Dec 31, 2019$193–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$17.46M+32.4%
Q2 FY2026Jun 30, 2026$19.89M+91.9%
Q1 FY2026Mar 31, 2026$22.19M+319.5%
Q4 FY2025Dec 31, 2025$14.44M+7.1%
Q3 FY2025Sep 30, 2025$13.18M+137.2%
Q2 FY2025Jun 30, 2025$10.36M+67.7%
Q1 FY2025Mar 31, 2025$5.29M-55.8%
Q4 FY2024Dec 31, 2024$13.48M-42.3%
Q3 FY2024Sep 30, 2024$5.56M+11.8%
Q2 FY2024Jun 30, 2024$6.18M-44.6%
Q1 FY2024Mar 31, 2024$11.97M+6.4%
Q4 FY2023Dec 31, 2023$23.37M+26.2%
Q3 FY2023Sep 30, 2023$4.97M-78.6%
Q2 FY2023Jun 30, 2023$11.15M-42.6%
Q1 FY2023Mar 31, 2023$11.26M-51.9%
Q4 FY2022Dec 31, 2022$18.52M-37.6%
Q3 FY2022Sep 30, 2022$23.19M-30.8%
Q2 FY2022Jun 30, 2022$19.42M-45.8%
Q1 FY2022Mar 31, 2022$23.42M+315.0%
Q4 FY2021Dec 31, 2021$29.69M+238.9%
Q3 FY2021Sep 30, 2021$33.49M+91419.7%
Q2 FY2021Jun 30, 2021$35.80M+230294.1%
Q1 FY2021Mar 31, 2021$5.64M+2750.9%
Q4 FY2020Dec 31, 2020$8.76M+4538999.5%
Q3 FY2020Nov 30, 2020$36.60K-72.8%
Q2 FY2020Aug 31, 2020$15.54K-92.6%
Q1 FY2020May 31, 2020$197.98K-27.7%
Q4 FY2019Dec 31, 2019$193-100.0%
Q3 FY2019Nov 30, 2019$134.31K-36.4%
Q2 FY2019Aug 31, 2019$211.24K–
Q1 FY2019May 31, 2019$273.69K–
Q3 FY2018Nov 30, 2018$400.96K–
Q2 FY2018Aug 31, 2018$211.24K–
Q1 FY2018Mar 19, 2018$0–

More Reviva Pharmaceuticals figures

See a number that looks wrong?